313 related articles for article (PubMed ID: 1985878)
21. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults.
International Collaboration on HIV and Cancer
J Natl Cancer Inst; 2000 Nov; 92(22):1823-30. PubMed ID: 11078759
[TBL] [Abstract][Full Text] [Related]
22. Incidence of Kaposi's sarcoma in a cohort of homosexual men infected with the human immunodeficiency virus type 1. The Multicenter AIDS Cohort Study Group.
Jacobson LP; Muñoz A; Fox R; Phair JP; Dudley J; Obrams GI; Kingsley LA; Polk BF
J Acquir Immune Defic Syndr (1988); 1990; 3 Suppl 1():S24-31. PubMed ID: 2395082
[TBL] [Abstract][Full Text] [Related]
23. The effect of HAART and calendar period on Kaposi's sarcoma and non-Hodgkin lymphoma: results of a match between an AIDS and cancer registry.
Pipkin S; Scheer S; Okeigwe I; Schwarcz S; Harris DH; Hessol NA
AIDS; 2011 Feb; 25(4):463-71. PubMed ID: 21139489
[TBL] [Abstract][Full Text] [Related]
24. The epidemiology of AIDS-associated Kaposi's sarcoma in Italy.
Serraino D; Zaccarelli M; Franceschi S; Greco D
AIDS; 1992 Sep; 6(9):1015-9. PubMed ID: 1388890
[TBL] [Abstract][Full Text] [Related]
25. AIDS-related secular trends in cancer in Los Angeles County men: a comparison by marital status.
Bernstein L; Levin D; Menck H; Ross RK
Cancer Res; 1989 Jan; 49(2):466-70. PubMed ID: 2910464
[TBL] [Abstract][Full Text] [Related]
26. Risk of Kaposi's sarcoma and sexual practices associated with faecal contact in homosexual or bisexual men with AIDS.
Beral V; Bull D; Darby S; Weller I; Carne C; Beecham M; Jaffe H
Lancet; 1992 Mar; 339(8794):632-5. PubMed ID: 1347337
[TBL] [Abstract][Full Text] [Related]
27. Kaposi's sarcoma and non-Hodgkin's lymphoma incidence trends in AIDS Clinical Trial Group study participants.
Rabkin CS; Testa MA; Huang J; Von Roenn JH
J Acquir Immune Defic Syndr; 1999 Aug; 21 Suppl 1():S31-3. PubMed ID: 10430216
[TBL] [Abstract][Full Text] [Related]
28. High-grade non-Hodgkin's lymphoma in patients with AIDS.
Ziegler JL; Bragg K; Abrams D; Beckstead J; Cogan M; Volberding P; Baer D; Wilkinson L; Rosenbaum E; Grant K
Ann N Y Acad Sci; 1984; 437():412-9. PubMed ID: 6598309
[TBL] [Abstract][Full Text] [Related]
29. Malignant tumors and AIDS.
Nasti G; Vaccher E; Errante D; Tirelli U
Biomed Pharmacother; 1997; 51(6-7):243-51. PubMed ID: 9309244
[TBL] [Abstract][Full Text] [Related]
30. Composite risk score for Kaposi's sarcoma based on a case-control and longitudinal study in the Multicenter AIDS Cohort Study (MACS) population.
Armenian HK; Hoover DR; Rubb S; Metz S; Kaslow R; Visscher B; Chmiel J; Kingsley L; Saah A
Am J Epidemiol; 1993 Aug; 138(4):256-65. PubMed ID: 8356966
[TBL] [Abstract][Full Text] [Related]
31. The epidemiology of acquired immunodeficiency syndrome and associated tumours in Europe.
Serraino D; Franceschi S; Tirelli U; Monfardini S
Ann Oncol; 1992 Sep; 3(8):595-603. PubMed ID: 1450040
[TBL] [Abstract][Full Text] [Related]
32. Factors associated with Kaposi's sarcoma in a cohort of homosexual and bisexual men.
Kaldor JM; Tindall B; Williamson P; Elford J; Cooper DA
J Acquir Immune Defic Syndr (1988); 1993 Oct; 6(10):1145-9. PubMed ID: 8105074
[TBL] [Abstract][Full Text] [Related]
33. Declines in proportion of Kaposi's sarcoma among cases of AIDS in multiple risk groups in New York City.
Des Jarlais DC; Stoneburner R; Thomas P; Friedman SR
Lancet; 1987 Oct; 2(8566):1024-5. PubMed ID: 2889930
[TBL] [Abstract][Full Text] [Related]
34. Is the human immunodeficiency virus-related Kaposi's sarcoma epidemic coming to an end? Insights from the Tricontinental Seroconverter Study.
Veugelers PJ; Strathdee SA; Moss AR; Page KA; Tindall B; Schechter MT; Coutinho RA; van Griensven GJ
Epidemiology; 1995 Jul; 6(4):382-6. PubMed ID: 7548345
[TBL] [Abstract][Full Text] [Related]
35. Kaposi's sarcoma among homosexual and bisexual men enrolled in the San Francisco City Clinic Cohort Study.
Lifson AR; Darrow WW; Hessol NA; O'Malley PM; Barnhart L; Jaffe HW; Rutherford GW
J Acquir Immune Defic Syndr (1988); 1990; 3 Suppl 1():S32-7. PubMed ID: 2395083
[TBL] [Abstract][Full Text] [Related]
36. Malignancies in the AIDS patient: natural history, treatment strategies, and preliminary results.
Longo DL; Steis RG; Lane HC; Lotze MT; Rosenberg SA; Preble O; Masur H; Rook AH; Fauci AS; Jacob J
Ann N Y Acad Sci; 1984; 437():421-30. PubMed ID: 6598311
[TBL] [Abstract][Full Text] [Related]
37. AIDS and cancer registry linkage: measurement and enhancement of registry completeness. The National AIDS/Cancer Match Study Group.
Coté TR; O'Brien TR; Ward JW; Wilson SE; Blattner WA
Prev Med; 1995 Jul; 24(4):375-7. PubMed ID: 7479628
[TBL] [Abstract][Full Text] [Related]
38. The impact of highly active antiretroviral therapy on the incidence and outcomes of AIDS-defining cancers in Southern Alberta.
Gingues S; Gill MJ
HIV Med; 2006 Sep; 7(6):369-77. PubMed ID: 16903981
[TBL] [Abstract][Full Text] [Related]
39. Variants of Kaposi's sarcoma in Southern Africa. A retrospective analysis (1980-1992).
Stein ME; Lachter J; Spencer D; Margolius L; Bezwoda WR
Acta Oncol; 1996; 35(2):193-9. PubMed ID: 8639315
[TBL] [Abstract][Full Text] [Related]
40. Human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) DNA in Kaposi's sarcoma lesions, AIDS Kaposi's sarcoma cell lines, endothelial Kaposi's sarcoma simulators, and the skin of immunosuppressed patients.
Dictor M; Rambech E; Way D; Witte M; Bendsöe N
Am J Pathol; 1996 Jun; 148(6):2009-16. PubMed ID: 8669485
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
